| Ticker: AFFX | 3380 Central Expressway | |
| Exchange: NASDAQ-National Market | Santa Clara, California 95051 | |
| Industry: Service | (408) 522-6000 |
| Type of Shares: | Common Shares | Filing Date: | 4/15/96 | |
| U.S. Shares: | 6,000,000 | Offer Date: | 6/6/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $11.00 - $13.00 | |
| Primary Shares: | 6,000,000 | Offer Price: | $15.00 | |
| Secondary Shares: | 0 | Gross Spread: | $1.03 | |
| Offering Amount: | $72,000,000 | Selling: | $0.61 | |
| Expenses: | $800,000 | Reallowance: | $0.10 | |
| Shares Out After: | 22,239,231 |
| Manager | Tier | Phone |
| Robertson, Stephens & Company | Lead Manager | (415) 989-8500 |
| CS First Boston | Co-manager | (212) 909-3312 |
| Montgomery Securities | Co-manager | 4156272220 |
| Auditor: Ernst & Young | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 3/31/96 | 3/31/95 | 3/31/96 | ||
| Revenue: | $4.63 | $1.42 | $0.85 | Assets: | $41.19 |
| Net Income: | -$10.75 | -$3.92 | -$2.17 | Liabilities: | $6.53 |
| EPS: | -$0.61 | -$0.22 | -$0.12 | Equity: | $34.65 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company has developed and intends to establish its GeneChip system as the platform of choice for acquiring, analyzing and managing complex genetic information in order to improve the diagnosis, monitoring and treatment of disease. The company's system consists of disposable DNA probe arrays containing gene sequences on a chip, instruments to process the probe arrays, and software to analyze and manage genetic information. The company commenced commercial sales of the GeneChip system and an HIV probe array for research use in April 1996. The company manufactures its DNA probe arrays using an innovative and proprietary process that combines photolitho-graphic fabrication techniques from the semiconductor industry with solid phase DNA synthesis to assemble large amounts of genetic information on a small glass chip called a probe array. The company can manufacture a number of identical DNA probe arrays on a glass wafer, which is then diced into individual probe arrays. Currently, each probe array manufactured by the company contains from 16,000 to more than 100,000 different DNA probes. |
| Use of Proceeds |
| The proceeds from the offering will be used for product development, manufacturing scale-up, research, sales and marketing, capital equipment, working capital and other general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.